ARCHIVES

Imbruvica Improves PFS, OS In Phase III CLL Study

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

Adding Velcade Increased Overall Survival By 13.3 Months at Five-Year Analysis

December 30, 2011

NCI To Proceed With Guidelines Unless Board Strongly Disagree

May 9, 1980

DCE Board Approves Study of Breast Cancer On Long Island

June 17, 1994

Constance Percy Retires From NCI After 30 Years.

November 10, 2000

Clara Bloomfield To Receive ASCO’s Karnofsky Award. V. Craig Jordan Named Lombardi Scientific Director

April 17, 2009

FDA Plans Greater Disclosures Over Wide Range Of Activities

May 21, 2010